Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 clinical study for BLU-5937 for the treatment of chronic cough.

Trial Profile

Phase 1 clinical study for BLU-5937 for the treatment of chronic cough.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Jul 2018

At a glance

  • Drugs BLU-5937 (Primary)
  • Indications Cough
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 26 Jul 2018 New trial record
    • 09 Jul 2018 According to BELLUS Health media release, dosing has been initiated in healthy subjects .
    • 09 Jul 2018 According to BELLUS Health media release, results from this study is expected in the fourth quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top